Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addiction, cognition, and mental health implications of these metabolic drugs.
Key findingReview of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addic
What the researchers found
Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addiction, cognition, and mental health implications of these metabolic drugs.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Review covers tirzepatide as a dual GLP-1/GIP agonist and its effects on insulin secretion, appetite regulation, and brain reward circuits.
How the study worked
In publication.
Who was studied
Review covering GLP-1/GIP drug users across psychological and behavioral studies
What this study cannot tell us
In publication.
How to read the evidence
Based on study design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide therapeutic knowledge.
Questions still open
- Long-term implications?
- Comparison to evidence?
- Next research?
Common questions
What does this mean?
How reliable?
Read the original research
Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review.
Journal of diabetes and metabolic disorders, 24(2), 253
Citation
Ameer, Fatima; Villacres, Nicole Yañez; Bustos, Daniel; Shah, Pari C; Appah, Noble; Luzaya, Galilee N; Corradi, Francesca; Bakare, Ifeoluwa S; Trujillo, Juan D; Mylavarapu, Maneeth; Mowo-Wale, Adetola; Silva, Alisson Barbosa. (2025). Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review.. Journal of diabetes and metabolic disorders, 24(2), 253. https://doi.org/10.1007/s40200-025-01770-x